Samuel Lanyon, Chairman & Interim Chief Executive at Lumos Diagnostics Holdings Ltd., holds 979.37K shares in Lumos Diagnostics Holdings Ltd. (Ticker: AU:LDX). Most recently, Samuel Lanyon Bought AU$285,714 shares of Lumos Diagnostics Holdings Ltd. on Aug 03, 2023 for an estimated value of 20.00K.